💥iPSC technology in action: Exploring patients, germline mutations, the DDX41 gene, CRISPR, reprogramming and bone marrow organoids. Curious about the bone marrow microenvironment? Join me at ASH my poster presentation next month to dive into these questions! #ASH24

Thanks for highlighting our work.

For reviewer 3

Congratulations to Kehan Ren PhD for such a great award!!

A fantastic ASH presidential reception with president Mohan Dr. Mohan Narla #ASH24

The future of #BloodCancer research is bright!💡🙌 Last night, we acknowledged the incredible work of our LLS Career Development Program Achievement awardees during #ASH24. 🎉 🔬 Elvin Wagenblast of Icahn School of Medicine at Mount Sinai 🔬 Daniel Pollyea of CU Anschutz Medical Campus 🔬 Johanna Melo-Cardenas of Northwestern Pathology

Excellent Inci Aydemir, MD !

She is a ⭐️

Really enjoyed the trip! Great to see old friends and celebrate Liang’s career! Keisuke Ito_Lab

Happy #TBT from NU Pathology📷 Looking back on our incredible growth!

Welcome future #PurplePath superstars! We can’t to meet you all. Welcome to Northwestern Pathology and Chicago! 💜 #PathMatch25 #Path2Path #Match2025

Amazing platform presentation by Dr. Jon Aldinger on accelerated CLL morphology and biology Northwestern Pathology

Great to reconnect with everyone at our Annual USCAP Alumni Reception in Boston this past Monday. Thanks to all who joined! 🥂💜#PurplePath

Then and now, Northwestern Pathology remains dedicated to excellence. #TBT #Pathology #PurplePath

The latest edition of Northwestern Pathology’s newsletter, The Scope, can be viewed here: new.express.adobe.com/webpage/el4wYo…

Excited to share our latest publication on how PPIL2 promotes myeloproliferative neoplasms by degrading p53. Congratulations to our outstanding postdocs Pan Wang and Xu Han—who will soon launch his independent lab at Central South University in China. jci.org/articles/view/…

Two weeks ago, we celebrated an incredible group of residents and fellows at our graduation ceremony! We are so proud of their accomplishments and grateful for the impact they’ve had on our department. Wishing them all the best in their next chapter! #PurplePath

Ameliorating myeloproliferative neoplasms with cyclosporin A in preclinical models— Peng Ji & team Northwestern Feinberg School of Medicine discover PPIL2 as a target of the JAK2/STAT5 pathway that promotes myeloproliferation through p53 degradation: jci.org/articles/view/…

ICYMI: Ameliorating myeloproliferative neoplasms with cyclosporin A in preclinical models— Peng Ji & team Northwestern Feinberg School of Medicine discover PPIL2 as a target of the JAK2/STAT5 pathway that promotes myeloproliferation through p53 degradation: jci.org/articles/view/…